Randall W. King, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitosis | 24 | 2020 | 1208 | 2.670 |
Why?
|
| Ubiquitin | 12 | 2023 | 852 | 1.700 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 7 | 2012 | 168 | 1.360 |
Why?
|
| Diamines | 3 | 2020 | 59 | 1.340 |
Why?
|
| Carbamates | 3 | 2020 | 196 | 1.210 |
Why?
|
| Ubiquitination | 12 | 2023 | 1012 | 1.200 |
Why?
|
| Cyclin B1 | 6 | 2020 | 52 | 1.170 |
Why?
|
| Proteasome Endopeptidase Complex | 15 | 2017 | 1338 | 1.000 |
Why?
|
| Cyclin B | 8 | 2016 | 108 | 0.950 |
Why?
|
| Polyploidy | 3 | 2010 | 114 | 0.920 |
Why?
|
| Chromosomes, Human | 3 | 2013 | 457 | 0.910 |
Why?
|
| Tosylarginine Methyl Ester | 2 | 2014 | 4 | 0.900 |
Why?
|
| Proteomics | 3 | 2023 | 3638 | 0.720 |
Why?
|
| Time-Lapse Imaging | 3 | 2020 | 195 | 0.710 |
Why?
|
| Cell Cycle Proteins | 12 | 2020 | 3462 | 0.690 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2020 | 563 | 0.630 |
Why?
|
| Pyrroles | 2 | 2021 | 1146 | 0.580 |
Why?
|
| Aneuploidy | 3 | 2011 | 530 | 0.530 |
Why?
|
| Enzyme Inhibitors | 4 | 2021 | 3798 | 0.480 |
Why?
|
| Cytokinesis | 4 | 2011 | 177 | 0.480 |
Why?
|
| RNA Interference | 4 | 2012 | 2889 | 0.470 |
Why?
|
| Interphase | 3 | 2011 | 226 | 0.460 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2011 | 1375 | 0.450 |
Why?
|
| Xenopus | 10 | 2012 | 712 | 0.420 |
Why?
|
| Genetics | 2 | 2004 | 112 | 0.420 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 6 | 2014 | 195 | 0.410 |
Why?
|
| Cyclins | 7 | 1996 | 603 | 0.400 |
Why?
|
| Chromosome Segregation | 3 | 2015 | 235 | 0.380 |
Why?
|
| Ovum | 4 | 2012 | 189 | 0.370 |
Why?
|
| HeLa Cells | 6 | 2020 | 3128 | 0.370 |
Why?
|
| Nondisjunction, Genetic | 2 | 2008 | 24 | 0.360 |
Why?
|
| Cyclin D1 | 1 | 2012 | 463 | 0.360 |
Why?
|
| Centrosome | 2 | 2008 | 201 | 0.350 |
Why?
|
| RNA, Double-Stranded | 1 | 2010 | 290 | 0.340 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 720 | 0.330 |
Why?
|
| Ubiquitin Thiolesterase | 4 | 2017 | 449 | 0.330 |
Why?
|
| Arginine | 2 | 2012 | 944 | 0.330 |
Why?
|
| Microscopy, Fluorescence | 5 | 2012 | 2699 | 0.320 |
Why?
|
| Cell Extracts | 4 | 2012 | 138 | 0.310 |
Why?
|
| Genetic Techniques | 1 | 2010 | 435 | 0.310 |
Why?
|
| Ubiquitins | 5 | 1996 | 384 | 0.300 |
Why?
|
| Substrate Specificity | 5 | 2021 | 1801 | 0.300 |
Why?
|
| Proteins | 6 | 2010 | 6103 | 0.290 |
Why?
|
| Protein Binding | 9 | 2015 | 9386 | 0.280 |
Why?
|
| Cell Cycle | 6 | 2011 | 2967 | 0.280 |
Why?
|
| Kinetochores | 1 | 2007 | 194 | 0.270 |
Why?
|
| Protein Biosynthesis | 3 | 2010 | 2126 | 0.270 |
Why?
|
| Binding Sites | 7 | 2020 | 6114 | 0.270 |
Why?
|
| Curriculum | 4 | 2023 | 3605 | 0.270 |
Why?
|
| Combinatorial Chemistry Techniques | 3 | 2005 | 129 | 0.260 |
Why?
|
| Cell Line | 12 | 2020 | 15997 | 0.260 |
Why?
|
| Sulfanilic Acids | 1 | 2004 | 13 | 0.260 |
Why?
|
| Microtubules | 5 | 2020 | 1090 | 0.250 |
Why?
|
| Proteome | 1 | 2014 | 1799 | 0.250 |
Why?
|
| Amino Acid Motifs | 2 | 2020 | 936 | 0.240 |
Why?
|
| Cells | 1 | 2005 | 168 | 0.240 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3505 | 0.230 |
Why?
|
| Ligases | 6 | 2006 | 333 | 0.230 |
Why?
|
| Ubiquitinated Proteins | 2 | 2015 | 34 | 0.230 |
Why?
|
| Veratrum Alkaloids | 1 | 2002 | 25 | 0.220 |
Why?
|
| Xenopus laevis | 3 | 2023 | 957 | 0.220 |
Why?
|
| Nocodazole | 2 | 2020 | 97 | 0.220 |
Why?
|
| Biology | 1 | 2005 | 294 | 0.210 |
Why?
|
| Anaphase | 6 | 1998 | 120 | 0.210 |
Why?
|
| Transcription, Genetic | 4 | 2013 | 7722 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2012 | 23403 | 0.200 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1547 | 0.200 |
Why?
|
| Animals | 31 | 2023 | 168757 | 0.190 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 686 | 0.190 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 791 | 0.190 |
Why?
|
| Problem-Based Learning | 2 | 2023 | 361 | 0.190 |
Why?
|
| Gene Library | 3 | 2012 | 1074 | 0.190 |
Why?
|
| Adenoviridae | 1 | 2005 | 1099 | 0.190 |
Why?
|
| Computational Biology | 1 | 2012 | 3521 | 0.170 |
Why?
|
| Quinolines | 1 | 2004 | 732 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 3772 | 0.170 |
Why?
|
| HCT116 Cells | 1 | 2020 | 408 | 0.170 |
Why?
|
| Protein Stability | 1 | 2020 | 557 | 0.160 |
Why?
|
| Maturation-Promoting Factor | 2 | 1994 | 26 | 0.160 |
Why?
|
| Genome | 2 | 2012 | 1808 | 0.150 |
Why?
|
| Gene Expression | 3 | 2010 | 7799 | 0.150 |
Why?
|
| Thinking | 1 | 2020 | 319 | 0.150 |
Why?
|
| Cloning, Molecular | 5 | 1999 | 4320 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 809 | 0.150 |
Why?
|
| Cadherins | 2 | 2020 | 907 | 0.140 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 1997 | 671 | 0.140 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2006 | 1888 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 976 | 0.140 |
Why?
|
| Amino Acid Sequence | 8 | 2013 | 13815 | 0.140 |
Why?
|
| Models, Biological | 5 | 2013 | 9583 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2010 | 13033 | 0.140 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 532 | 0.140 |
Why?
|
| Clinical Competence | 2 | 2020 | 4687 | 0.140 |
Why?
|
| Sister Chromatid Exchange | 1 | 2015 | 60 | 0.130 |
Why?
|
| Chromatin | 1 | 2007 | 2934 | 0.130 |
Why?
|
| Base Sequence | 4 | 2012 | 12797 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 1222 | 0.130 |
Why?
|
| Xenopus Proteins | 3 | 2012 | 433 | 0.130 |
Why?
|
| Nuclear Proteins | 4 | 2020 | 5853 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 2 | 2012 | 1081 | 0.130 |
Why?
|
| Telomerase | 1 | 2020 | 730 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2010 | 3752 | 0.120 |
Why?
|
| Phosphorylation | 5 | 2020 | 8436 | 0.120 |
Why?
|
| Lysine | 4 | 2012 | 1007 | 0.120 |
Why?
|
| Melphalan | 1 | 2016 | 431 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 1157 | 0.120 |
Why?
|
| Molecular Sequence Data | 7 | 2013 | 18111 | 0.120 |
Why?
|
| Cell Division | 3 | 2011 | 4568 | 0.120 |
Why?
|
| Cytoskeleton | 3 | 2010 | 1185 | 0.110 |
Why?
|
| CDC2 Protein Kinase | 2 | 2013 | 220 | 0.110 |
Why?
|
| Emergency Medicine | 1 | 2002 | 1207 | 0.110 |
Why?
|
| Pyridines | 2 | 2020 | 2825 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2002 | 2924 | 0.110 |
Why?
|
| Humans | 38 | 2023 | 744343 | 0.100 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 70 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2020 | 5535 | 0.100 |
Why?
|
| Immunoblotting | 2 | 2012 | 1682 | 0.100 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 1008 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 1701 | 0.100 |
Why?
|
| Untranslated Regions | 1 | 2010 | 31 | 0.100 |
Why?
|
| Education, Medical | 1 | 2023 | 1721 | 0.100 |
Why?
|
| Histone Demethylases | 1 | 2013 | 321 | 0.090 |
Why?
|
| S Phase | 2 | 2005 | 423 | 0.090 |
Why?
|
| Metaphase | 1 | 2010 | 151 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2010 | 159 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2014 | 1792 | 0.090 |
Why?
|
| Models, Molecular | 3 | 2016 | 5456 | 0.090 |
Why?
|
| Piperazines | 1 | 2020 | 2488 | 0.090 |
Why?
|
| Crystallography, X-Ray | 1 | 2014 | 2011 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2013 | 2256 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2020 | 4026 | 0.090 |
Why?
|
| Endopeptidases | 3 | 2010 | 772 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 6 | 2006 | 1861 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 2916 | 0.090 |
Why?
|
| DNA, Complementary | 3 | 2004 | 2050 | 0.080 |
Why?
|
| Cell Nucleus | 3 | 2007 | 2969 | 0.080 |
Why?
|
| Cell Death | 1 | 2014 | 1706 | 0.080 |
Why?
|
| Prodrugs | 1 | 2010 | 268 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2012 | 3023 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 500 | 0.080 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2008 | 45 | 0.080 |
Why?
|
| Apoptosis | 3 | 2016 | 9727 | 0.080 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2008 | 76 | 0.080 |
Why?
|
| tau Proteins | 1 | 2017 | 1868 | 0.080 |
Why?
|
| Hydrolysis | 2 | 2007 | 682 | 0.080 |
Why?
|
| Protein Transport | 3 | 2015 | 1988 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2017 | 4161 | 0.070 |
Why?
|
| Drug Design | 2 | 2004 | 1076 | 0.070 |
Why?
|
| Haplorhini | 1 | 2007 | 552 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2006 | 2752 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2005 | 78 | 0.070 |
Why?
|
| Insulin | 1 | 2020 | 6580 | 0.070 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 944 | 0.070 |
Why?
|
| Mice | 5 | 2020 | 81183 | 0.060 |
Why?
|
| Biological Transport | 1 | 2010 | 2118 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2004 | 55 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2005 | 853 | 0.060 |
Why?
|
| Ornithine Decarboxylase | 1 | 2004 | 63 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1783 | 0.060 |
Why?
|
| Educational Measurement | 2 | 2020 | 1210 | 0.060 |
Why?
|
| Adamantane | 1 | 2005 | 173 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2005 | 549 | 0.060 |
Why?
|
| Cell Shape | 1 | 2005 | 375 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 1801 | 0.060 |
Why?
|
| Neoplasms | 2 | 2011 | 21683 | 0.060 |
Why?
|
| Biochemistry | 1 | 2005 | 113 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2011 | 1640 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12072 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2011 | 2649 | 0.060 |
Why?
|
| DNA Replication | 2 | 2008 | 1399 | 0.060 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2004 | 131 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2010 | 3002 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 736 | 0.060 |
Why?
|
| Learning | 2 | 2023 | 1713 | 0.050 |
Why?
|
| Luciferases | 2 | 2004 | 733 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2004 | 1899 | 0.050 |
Why?
|
| Fungal Proteins | 2 | 1996 | 912 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2002 | 5788 | 0.050 |
Why?
|
| Telomere | 1 | 2008 | 910 | 0.050 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2001 | 23 | 0.050 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2002 | 170 | 0.050 |
Why?
|
| DNA Damage | 1 | 2012 | 2432 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 563 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 1364 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 1889 | 0.050 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 1005 | 0.050 |
Why?
|
| Histones | 1 | 2011 | 2599 | 0.050 |
Why?
|
| Yeasts | 2 | 2016 | 285 | 0.050 |
Why?
|
| Paclitaxel | 2 | 2015 | 1708 | 0.050 |
Why?
|
| Miniaturization | 1 | 2001 | 164 | 0.050 |
Why?
|
| Cell Communication | 1 | 2007 | 1621 | 0.050 |
Why?
|
| Patient Simulation | 1 | 2002 | 309 | 0.050 |
Why?
|
| Thiones | 1 | 1999 | 46 | 0.040 |
Why?
|
| Autophagy | 1 | 2007 | 1300 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2012 | 2088 | 0.040 |
Why?
|
| Kinetics | 3 | 2016 | 6473 | 0.040 |
Why?
|
| Plasmids | 3 | 2004 | 2307 | 0.040 |
Why?
|
| Colchicine | 1 | 2000 | 243 | 0.040 |
Why?
|
| Genome, Human | 1 | 2012 | 4420 | 0.040 |
Why?
|
| Neurons | 1 | 2017 | 9338 | 0.040 |
Why?
|
| Microspheres | 1 | 2001 | 777 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 5181 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 1997 | 6622 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2002 | 783 | 0.040 |
Why?
|
| Microtubule Proteins | 1 | 1997 | 61 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 3703 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2016 | 6314 | 0.040 |
Why?
|
| Cullin Proteins | 1 | 1998 | 180 | 0.040 |
Why?
|
| Sea Urchins | 1 | 1996 | 46 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2004 | 1990 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2007 | 2921 | 0.040 |
Why?
|
| Mutation | 4 | 2013 | 29786 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2013 | 12208 | 0.040 |
Why?
|
| Schizosaccharomyces | 2 | 1997 | 237 | 0.030 |
Why?
|
| Enzymes | 1 | 1997 | 266 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2016 | 167 | 0.030 |
Why?
|
| G1 Phase | 1 | 1996 | 415 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2015 | 110 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 880 | 0.030 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 1995 | 83 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 8428 | 0.030 |
Why?
|
| Genomics | 1 | 2010 | 5720 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 3327 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Artificial Intelligence | 1 | 2007 | 2214 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1995 | 547 | 0.030 |
Why?
|
| Zebrafish | 1 | 2005 | 2994 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2015 | 344 | 0.030 |
Why?
|
| Fungi | 1 | 1996 | 327 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 1997 | 895 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 19905 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2006 | 5021 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 2219 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 1539 | 0.030 |
Why?
|
| Teaching | 1 | 2020 | 1174 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 1799 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 1454 | 0.030 |
Why?
|
| Phenotype | 3 | 2005 | 16365 | 0.030 |
Why?
|
| Morpholines | 1 | 2015 | 571 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 594 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2020 | 1181 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2839 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1526 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 1999 | 2440 | 0.030 |
Why?
|
| Histone Chaperones | 1 | 2012 | 76 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2011 | 34 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2016 | 627 | 0.030 |
Why?
|
| Entosis | 1 | 2011 | 6 | 0.030 |
Why?
|
| Rad51 Recombinase | 1 | 2012 | 189 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2011 | 66 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2012 | 3494 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 474 | 0.020 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2012 | 165 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2012 | 208 | 0.020 |
Why?
|
| Carboxypeptidases | 1 | 2010 | 176 | 0.020 |
Why?
|
| Furans | 1 | 2011 | 194 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3396 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 440 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2013 | 1202 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 627 | 0.020 |
Why?
|
| Peptides | 1 | 2001 | 4409 | 0.020 |
Why?
|
| Mammals | 1 | 1994 | 1143 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 16689 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 19229 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 476 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2016 | 5179 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2007 | 68 | 0.020 |
Why?
|
| RNA-Binding Proteins | 2 | 2012 | 1903 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 279 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2007 | 210 | 0.020 |
Why?
|
| Adherens Junctions | 1 | 2007 | 90 | 0.020 |
Why?
|
| Pyrimidines | 1 | 1999 | 2942 | 0.020 |
Why?
|
| Algorithms | 1 | 2007 | 13881 | 0.020 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 794 | 0.020 |
Why?
|
| Methylation | 2 | 2004 | 1106 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2006 | 192 | 0.020 |
Why?
|
| Actins | 2 | 2007 | 2121 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2006 | 347 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8301 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2007 | 408 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2007 | 279 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2007 | 293 | 0.020 |
Why?
|
| Cognition | 1 | 2023 | 6770 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2007 | 437 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2011 | 1101 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2006 | 436 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4751 | 0.020 |
Why?
|
| Epitopes | 2 | 2004 | 2571 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4204 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2564 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 459 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 1708 | 0.010 |
Why?
|
| Female | 2 | 2012 | 380194 | 0.010 |
Why?
|
| Nitrogen | 1 | 2004 | 344 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 2004 | 212 | 0.010 |
Why?
|
| Lysosomes | 1 | 2007 | 893 | 0.010 |
Why?
|
| DNA Repair | 1 | 2012 | 2046 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14557 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2455 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2011 | 2504 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 595 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2004 | 626 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2001 | 322 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 2025 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2006 | 1189 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2007 | 3144 | 0.010 |
Why?
|
| Peptide Library | 1 | 2001 | 349 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10481 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2007 | 1741 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9438 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
| Molecular Motor Proteins | 1 | 1999 | 107 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 1060 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2203 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1999 | 410 | 0.010 |
Why?
|
| Light | 1 | 2004 | 1374 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1783 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 1998 | 171 | 0.010 |
Why?
|
| Chromosomes | 1 | 2000 | 596 | 0.010 |
Why?
|
| Aspergillus | 1 | 1996 | 85 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3846 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3870 | 0.010 |
Why?
|
| Tubulin | 1 | 2000 | 695 | 0.010 |
Why?
|
| Fertilization | 1 | 1997 | 196 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 1997 | 241 | 0.010 |
Why?
|
| Carcinoma | 1 | 2007 | 2375 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 5892 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1998 | 810 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 3617 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 3922 | 0.010 |
Why?
|
| Chromatids | 1 | 1993 | 63 | 0.010 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 1993 | 87 | 0.010 |
Why?
|
| Phylogeny | 1 | 1998 | 2803 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2004 | 4286 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11483 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 20822 | 0.000 |
Why?
|